Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole by Michele C. R. de Freitas et al.
fmicb-07-01465 September 16, 2016 Time: 10:20 # 1
ORIGINAL RESEARCH
published: 20 September 2016
doi: 10.3389/fmicb.2016.01465
Edited by:
Jose L. Martinez,
Spanish National Research Council,
Spain
Reviewed by:
Paul Stokes Hoffman,
University of Virginia, USA
Jozsef Soki,
University of Szeged, Hungary
*Correspondence:
Cláudio G. Diniz
claudio.diniz@ufjf.edu.br
Marisa F. Nicolás
marisa@lncc.br
Specialty section:
This article was submitted to
Antimicrobials, Resistance
and Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 03 July 2016
Accepted: 01 September 2016
Published: 20 September 2016
Citation:
de Freitas MCR, Resende JA,
Ferreira-Machado AB, Saji GDRQ,
de Vasconcelos ATR, da Silva VL,
Nicolás MF and Diniz CG (2016)
Exploratory Investigation
of Bacteroides fragilis Transcriptional
Response during In vitro Exposure
to Subinhibitory Concentration
of Metronidazole.
Front. Microbiol. 7:1465.
doi: 10.3389/fmicb.2016.01465
Exploratory Investigation of
Bacteroides fragilis Transcriptional
Response during In vitro Exposure to
Subinhibitory Concentration of
Metronidazole
Michele C. R. de Freitas1, Juliana A. Resende1, Alessandra B. Ferreira-Machado1,
Guadalupe D. R. Q. Saji2, Ana T. R. de Vasconcelos2, Vânia L. da Silva1,
Marisa F. Nicolás2* and Cláudio G. Diniz1*
1 Departamento de Parasitologia, Microbiologia e Imunologia, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil,
2 Laboratório de Bioinformática and Laboratório Nacional de Computação Científica, Petrópolis, Brazil
Bacteroides fragilis, member from commensal gut microbiota, is an important pathogen
associated to endogenous infections and metronidazole remains a valuable antibiotic
for the treatment of these infections, although bacterial resistance is widely reported.
Considering the need of a better understanding on the global mechanisms by
which B. fragilis survive upon metronidazole exposure, we performed a RNA-seq
transcriptomic approach with validation of gene expression results by qPCR. Bacteria
strains were selected after in vitro subcultures with subinhibitory concentration (SIC)
of the drug. From a wild type B. fragilis ATCC 43859 four derivative strains were
selected: first and fourth subcultures under metronidazole exposure and first and fourth
subcultures after drug removal. According to global gene expression analysis, 2,146
protein coding genes were identified, of which a total of 1,618 (77%) were assigned
to a Gene Ontology term (GO), indicating that most known cellular functions were
taken. Among these 2,146 protein coding genes, 377 were shared among all strains,
suggesting that they are critical for B. fragilis survival. In order to identify distinct
expression patterns, we also performed a K-means clustering analysis set to 15 groups.
This analysis allowed us to detect the major activated or repressed genes encoding for
enzymes which act in several metabolic pathways involved in metronidazole response
such as drug activation, defense mechanisms against superoxide ions, high expression
level of multidrug efflux pumps, and DNA repair. The strains collected after metronidazole
removal were functionally more similar to those cultured under drug pressure, reinforcing
that drug-exposure lead to drastic persistent changes in the B. fragilis gene expression
patterns. These results may help to elucidate B. fragilis response during metronidazole
exposure, mainly at SIC, contributing with information about bacterial survival strategies
under stress conditions in their environment.
Keywords: Bacteroides fragilis, RNA-seq, metronidazole, subinhibitory concentration, K-means clustering
analysis
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INTRODUCTION
The Gram negative anaerobic rod Bacteroides fragilis, a
member of the gut microbiota, remains as one of the
most important putative pathogen associated with endogenous
infections (Wexler, 2007; Brook, 2010). Since 1950, antimicrobial
agents have been widely used to treat different infectious
diseases, leading to dissemination of antimicrobial resistance.
The resistance phenomenon has dramatically increased among
human pathogens, especially resident microbiota, resulting in
only a few therapeutic options to treat infections related to
resistant bacteria (Andersson and Hughes, 2010).
As a common clinical practice, to treat infections caused
by B. fragilis, β-lactam drugs are usually prescribed, such
as piperacillin-tazobactam or carbapenems. Besides that,
metronidazole, clindamycin and even fluoroquinolones, are also
frequently prescribed (Brook, 2016). In any way, metronidazole
remains as drug of choice to treat anaerobic infections in which
B. fragilis is involved (Löfmark et al., 2010).
Metronidazole, a nitroimidazole drug, is a non-toxic prodrug
that requires the reduction of the nitro group to be converted
into toxic nitro anion radical or hydroxyl amine forms. It is
accepted that metronidazole enters the cell through diffusion,
and in the anaerobic environment a chemical reduction occurs
and the release of final products lead to a transmembrane
concentration gradient (Edwards, 1993a; Sisson et al., 2000).
After metronidazole intracellular reduction, inhibition of DNA
replication is observed followed by DNA synthesis and
RNA metabolism stop. Cell lysis may occur, suggesting that
nitroradicals interact with other cell components resulting in
membrane disruption (Diniz et al., 2000).
Metronidazole resistance mechanisms in B. fragilis are
complex, but it is highly suggested the lack of drug chemical
reduction due to decreased activity of cellular oxidoreductases
enzymes (ferredoxins) involved in electron transference (Diniz
et al., 2004). Additional mechanisms are thought to be associated
with drug inactivation by aminothiol radical scavengers and
radioprotectors, overexpression of recA gene encoding for major
DNA repair enzymes, mutation in feoAB gene encoding for
iron transport protein, and metronidazole reduction to non-toxic
amine derivative as result of nim genes expression (Narikawa
et al., 1991; Edwards, 1993b; Carlier et al., 1997; Steffens et al.,
2010; Vael et al., 2011; Veeranagouda et al., 2014).
Besides the biological drug-resistance mechanisms, the
widespread sometimes inappropriate uses are to be considered.
Add to that, the resident microbiota exposure to subinhibitory
concentrations (SIC), which may interfere with microbial
ecosystem, may also lead to changes in bacteria-bacteria and
bacteria-host relationships related to pleiotropic regulation in
bacterial gene expression, as an adaptive response (Bohnen, 1998;
Diniz et al., 2004). Under SIC of antimicrobial drugs, in vitro
studies reported cellular alterations related to the anaerobic
bacteria morphology, physiology, and protein expression (Diniz
et al., 2003; de Souza Filho et al., 2012; Freitas et al., 2015).
Considering this adaptive response to SIC of antimicrobial
drugs, elucidation of bacterial genome expression would lead to
a better understanding of microbial mechanisms to overcome
antimicrobial chemotherapy. In this study we carried out an
in vitro experimental design in order to evaluate transcriptional
response of B. fragilis exposed to SIC of metronidazole,
which allowed the observation differential expression of several
bacterial genes related to various metabolic pathways involved in
metronidazole response by anaerobes.
MATERIALS AND METHODS
Bacteria and Routine Culture Conditions
For routine culture, bacteria were grown in Brain Heart Infusion
broth (Himedia, Mumbai, India) supplemented with hemin
(Inlab, São Paulo, Brazil, 5 mg/mL), menadione (Inlab, São
Paulo, Brazil, 1 mg/mL), L-cysteine 0.1% w/v (Inlab, São Paulo,
Brazil) and metronidazole (Sigma-Aldrich, St. Louis, MO, USA),
1 µg/mL (whenever necessary), in anaerobic atmosphere (90%
N2, 10% CO2), at 37◦C. Cultures were let to grow until mid-log
phase. As described in Figure 1, for in vitro bacterial selection,
subcultures with or without metronidazole were performed in
48 h time point intervals up to 8 days. In this regard, from
the parent B. fragilis ATCC 43859 (wMtz), the Mtz2 strain
was selected after first subculture under metronidazole pressure,
and Mtz8 was selected after the fourth successive subculture
in the same condition. Further, rMtz2 strain was selected from
Mtz8 (first subculture) after drug removal, and rMtz8 strain was
subsequently selected after the fourth successive subculture in the
same condition. For each subculture, a 1% inoculum was used to
avoid accumulation of eventual dead cells.
Determination of Subinhibitory
Concentration (SIC) of Metronidazole
Metronidazole susceptibility pattern was determined by the
broth dilution method according to the Clinical and Laboratory
Standards Institute guidelines (CLSI, 2012). Briefly, 0.1 mL of
a 1.0 McFarland suspension of parent B. fragilis strain was
inoculated in Brucella broth (Himedia) tubes with increasing
concentration of metronidazole ranging from 0.06 to 64 µg/mL.
After 48 h of incubation, the minimum inhibitory concentration
(MIC) was determined. The SIC of metronidazole was considered
0.5 MIC.
Quantification of Bacteria
Bacterial quantification was performed by real-time
quantitative PCR (qPCR). For the PCR reaction, B. fragilis
specific primers targeting 16S rRNA gene were used: Bf
(CTGAACCAGCCAAGTAGCG) and Bf-F5 (CCGCAAA
CTTTCACAACTGACTT) (IDT Integrated DNA Technologies).
The quantitative analysis were performed on the Corbett Rotor
Gene 6000 (Corbett Life Science, Mortlake, NSW, Australia)
using SYBR Green PCR Master Mix (Applied Biosystems,
Foster City, CA, USA) to monitor the synthesis of double
stranded DNA. Reactions were assembled in a final volume of
25 µL according manufacturer’s instructions, and amplification
conditions as described before (Liu et al., 2003). Each run
included a standard curve in duplicate, and each sample was run
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FIGURE 1 | Experimental design. Rationale for in vitro bacterial growth, sampling collection points, RNA-seq approach and analyzes.
in duplicate. The specificity of amplification was determined by
analyzing the dissociation curves.
RNA Extraction and mRNA Enrichment
and cDNA Libraries
The total RNA was extracted from 1.0 mL of each B. fragilis
culture by using the RNeasy mini kit (Qiagen, Venlo, The
Netherlands) according to the manufacturer protocols. The
RNA extracts were DNase treated (RQ1 Rnase-free Dnase
Kit, Promega). The MICROBExpressTM Bacterial mRNA
Enrichment Kit (Ambion, Austin, TX, USA) was used to
deplete the prokaryotic ribosomal RNA. The RNA quality
was evaluated through on-chip microfluidic electrophoresis
(Prokaryote Total RNA Pico kit, Bioanalyzer Instruments
2100, Agilent Technologies, Santa Clara, CA, USA). The RNA
extracts with RNA integrity number (RIN) > 8 were considered
to be of sequencing quality and cDNA libraries were then
constructed using the cDNA Rapid Library Preparation Method
(Roche Diagnostics, Roswell, GA, USA). In order to get an
equimolar amount among libraries, we used the KAPA Library
Quantification Kit (Kapa Biosystems, Wilmington, MA, USA).
RNA-seq and Transcriptomic Data
Analysis
Sequencing of cDNA libraries were carried out at Computational
Genomics Unity Darcy Fontoura de Almeida (UGCDFA)
at National Laboratory of Scientific Computation (LNCC,
Petropolis, RJ, Brazil) using the platform Genome FLX sequencer
and FLX Titanium chemistry (454 Life Sciences/Roche),
according to the manufacturer’s protocols. For data analysis,
firstly libraries reads were extracted and the SFF files (Standard
Flowgram Format) were converted into FASTA and QUAL
files. A filtering step was performed in order to remove the
reads with low quality. Further, the filtered RNA-seq reads were
mapped to B. fragilis NCTC 9343 (CR626927) reference genomic
sequence using Bowtie 2 (Langmead and Salzberg, 2012), and
the remaining ribosomal RNA sequences were subsequently
removed using SAMtools (Li et al., 2009). It was also performed
another filtering step in order to remove the replicates sequences
by CD-HIT (Fu et al., 2012). Finally, the number of reads
mapped to each gene was counted using HTSeq-count (Anders
et al., 2015). The edgeR package from R/BioConductor was
used to normalize the mapped count data (Anders et al., 2013).
A Venn diagram was constructed to identify the number of
shared and exclusive expressed genes in each experimental
condition. Transcripts were classified based on Gene Ontology
(GO)1 and Clusters of Orthologous Groups (COG) annotations2
with additional information retrieved from UniProtKB3 and
literature. Further bioinformatics tools and clustering analysis
was performed in R statistical software environment4. Clustering
analysis was done with standard k-means from standardized
expression values, with the Pearson correlation as distance
measure (Brinsmade et al., 2014; Cornforth et al., 2014).
Additionally, from clustering dataset, a gene expression analysis
was performed using the Bioconductor package edeR (Robinson
et al., 2010), in order to get the Log fold-change (LogFC)
and P-value statistics for comparisons between each pair of
treatments.
DNA Sequencing Validation
To validate the transcription levels obtained from RNA-seq,
real-time quantitative PCR (qPCR) was performed to compare
gene expression patterns. The RNA extracts were used as
template. Six representative genes of those identified by RNA-
seq were tested (Table 2). For cDNA synthesis, ImProm-IITM
Reverse Transcription System (Promega) was used. The qPCR
experiments were performed using Corbett Rotor Gene 6000
(Corbett Life Science) with three technical replicates for each
sample. Reactions were conducted in 25 µL reaction mixtures
containing 1 µL of diluted cDNA, 2X Rotor-gene SYBR Green
PCR Master Mix (Qiagen, Valencia, CA, USA), and gene-specific
primers (Table 2). The qPCR reactions included initial heating
1http://geneontology.org
2http://www.ncbi.nlm.nih.gov/COG
3http://www.uniprot.org/help/uniprotkb
4http://www.r-project.org
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for 10 min at 95◦C, followed by 40 cycles of 95◦C, 10 s; 60◦C,
15 s; 72◦C 20 s. To calculate fold changes, the 2−11Ct method
was used with the constitutively expressed 16S ribosomal RNA
gene as a control for normalization.
Data availability
A NCBI BioProject was created (accession number
PRJNA338776). The expression values (fold-changes relative to
each condition) are available in Additional File 3, and raw data is
available from the corresponding authors upon request.
RESULTS AND DISCUSSION
Overview of the B. fragilis Transcriptome
by RNA-seq Approach
The B. fragilis strains used in this study are listed in Table 1 and
the experimental design is presented in Figure 1. Considering the
minimal inhibitory concentration (MIC) determined as 2 µg/mL
for the parent strain (wMtz), in agreement with CLSI (CLSI,
2012), SIC of metronidazole was defined as 1 µg/mL (0.5 MIC).
A reduced sensitivity to metronidazole was observed for B. fragilis
strains selected in vitro after successive subcultures in either
presence or absence of drug (+2log2 MIC). Results from bacterial
quantification showed that metronidazole was not able to
TABLE 1 | Strains used in this study and metronidazole susceptibility
patterns.
Strains Phenotype MTZ MICa
(µg/mL)
Reference
wMtz Parent Bacteroides fragilis
ATCC 43859 (wMtz.1 and
wMtz.2 in supplementary files,
after two replicates).
2.0 Myers et al., 1987
Mtz2 Strains derived from wMtz
selected after first subculture in
SICs of MTZ, 1 µg/mL (Mtz2.1
and Mtz2.2 in supplementary
files, after two replicates).
8.0 This study
Mtz8 Strains derived from wMtz
selected after fourth successive
subculture in SICs of MTZ
(Mtz8.1 and Mtz8.2 in
supplementary files after two
replicates).
8.0 This study
rMtz2 Strains derived from Mtz8
selected after first subculture in
absence of MTZ (rMtz2.1 and
rMtz2.2 in supplementary files
after two replicates).
8.0 This study
rMtz8 Strains derived from Mtz8
selected after fourth successive
subculture in the absence of
MTZ (rMtz8.1 and rMtz8.2 in
supplementary files, after two
replicates).
8.0 This study
aMTZ, metronidazole; MIC, minimal inhibitory concentration determined by broth
dilution method according CLSI guidelines for anaerobic bacteria (CLSI, 2012).
interfere with B. fragilis population levels. Quantification values
based on qPCR targeting to 16S rRNA gene ranged between
8.57 (± 0.22) and 8.55 (± 0.06) log copy/mL if considering the
initial cultures under metronidazole pressure and the further
culturing without drug, respectively. The purpose of this study
was to determine genome-wide RNA profiles in B. fragilis either
by the response to the stress imposed by SIC of metronidazole,
as well as after drug removal. Sequence reads were mapped to
the annotated B. fragilis NCTC 9343 (CR626927) genome. The
pattern of relative gene expression was similar between the two
biological replicates with a correlation coefficient of r = 0.97,
r = 0.96, r = 0.75, r = 0.98, r = 0.96 for B. fragilis ATCC 43859
considering each tested condition, respectively (Figure 2).
The expression analysis demonstrated that approximately
93% of the B. fragilis ATCC 43859 reads mapped to B. fragilis
NCTC 9343 genome. The reads mapping to the reference
genome revealed a total of 2,146 expressed genes among all
samples of B. fragilis ATCC 43859, which represented 51%
of complete protein coding genes annotated in this bacterial
strain (Supplementary Table S1). From the expressed genes, a
total of 1,618 (77%) were assigned to a Gene Ontology term
(GO), biological process, molecular function or cellular location
term, suggesting that most of the known cellular functions were
identified. The total number of genes identified per each sample
was equal to 843, 1032, 856, 939, 1052 for wMtz, Mtz2, Mtz8,
rMtz2, rMtz8, respectively (Supplementary Table S1).
We also determined the number of expressed genes shared
among all strains, which were 377 genes that may be regarded
as a common core critical for B. fragilis survival. Recently,
other authors determined that among the 4,326 protein coding
genes of B. fragilis 638R, 550 were essential for its survival
(Veeranagouda et al., 2014). So, we examined these 550 essential
genes and compared to the shared core determined in this
study (Figure 3; Supplementary Table S2). In fact, this revealed
40 genes that are homologous between both divergent strains,
which include most housekeeping COG functions, such as
translation, ribosomal structure, and biogenesis (12 genes), DNA
replication, recombination, and repair (five genes), cell division
and chromosome partitioning (three genes), transcription
(three genes); coenzyme metabolism (three genes) and post-
translational modification (two genes), among others (Figure 3).
Considering the wild type strain (wMtz), only 61 genes
were exclusively expressed, whereas 154 genes (Mtz2 and Mtz8)
were expressed exclusively under metronidazole pressure. After
drug removal (rMtz2 and rMtz8) the number of exclusively
expressed genes increased to 629. By comparing the exclusive
genes from wMtz, Mtz2 and Mtz8, no shared COG or common
GO function were observed. With regards to bacteria selected
under drug pressure (Mtz strains) and those selected after
drug removal (rMtz strains), 27 shared COG or common GO
functions were observed (Supplementary Table S2). Besides that,
by comparing exclusive genes from wMtz and rMtz strains,
shared COG or common GO functions were only attributed to
proteins of uncharacterized functions. These observations may
suggest, at the end, that the strains collected after metronidazole
removal (rMtz) might be functionally more similar to those
cultured under drug pressure (Mtz). Although we tested SIC
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FIGURE 2 | Gene relative expression analyses. (A) Heatmap showing the relative expression levels of each transcript (column) in each sample (row). The image
was prepared in R (http://www.r-project.org). (B) Boxplot displaying the relative expression patterns to normalized replicates.
of metronidazole, previous studies suggested a complex shift in
B. fragilis metronidazole resistant-strain resulting in both down-
and up-regulation of expressed proteins (Diniz et al., 2004).
In this regard, our results show that even when the growth
conditions are restored, similarly to the initial state without
drug, the resulting strain, having gone through the SIC of
metronidazole selective pressure, had drastic changes in their
whole gene expression patterns (Figure 2).
B. fragilis Genome-Wide RNA Profiles in
Response to Subinhibitory
Concentration of Metronidazole
It is discussed the efficiency regarding GS FLX 454 Roche
platform when considered to transcriptomic experiments, if
compared to other methodological approaches (D’Amore et al.,
2016). In order to overcome, issues related to the coverage
limitation, once GS FLX 454 Roche platform was the only
infrastructure available, we have chosen to explore the whole
normalized RNA-seq data from the five sampling points to
identify genes that potentially contribute to the response to
SIC of metronidazole. The normalization was determined by
the k-means clustering and validated by qPCR gene expression
assays since the biological replicates showed a good correlation
(Brinsmade et al., 2014; Cornforth et al., 2014).
Thus, the dataset was subjected to k-means clustering, set to 15
to identify distinct expression patterns (Figure 4; Supplementary
Table S3). To determine up and down-regulations along to
their statistical significance (P ≤ 0.05) between treatments, a
differential gene expression analysis was performed. Figure 4
indicates the normalized expression levels of the clusterized
genes for all experimental conditions over 48 h subcultures.
Inside each of the 15 clusters, the number of genes per cluster
is presented. In general, genes located in the same operon
or with related functions fell into the same cluster or at
least two clusters, supporting the number of clusters used in
the calculations. For example, several genes involved in the
peptidoglycan biosynthesis pathway (i.e., murEDC, mraY) fell
into cluster 14, whereas the gene mraY was designated to
cluster 9. Genes encoding for the ATP synthase (i.e., atpDGA)
operon were assigned to clusters 12 and 4. Genes involved in
the leucine biosynthetic process (i.e., leuABC) were assigned
to clusters 11 and 6, and genes encoding for the acetyl
coenzyme A carboxylase (ACC) complex (i.e., accCD) fell into
cluster 12.
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FIGURE 3 | Venn diagram. Overview of shared or exclusive gene expression in all tested strains. It was highlighted the number of genes in the core, which were
found to be homologous to the strain 638R. The image was prepared with jvenn, a JavaScript library (Bardou et al., 2014).
Therefore, based on the gene expression patterns revealed
by K-means clustering and qPCR validation (section after) we
shall discuss the main metabolic pathways which were already
described in the literature as being involved with B. fragilis
response to SIC of metronidazole.
As long as metronidazole has a nitro group from its 5-
nitroimidazole structure that must be reduced for the drug to
become active inside prokaryotic cell, the resulting substances
may be related to strand DNA breakage, including the possible
inhibition of DNA repair mechanisms (Diniz et al., 2000).
Firstly, the reduction occurs in one-electron step where the nitro
moiety RNO2 is reduced to form a superoxide anion (RNO2−),
and subsequent steps form a nitrous derivative (RNO), to a
nitrous free radical (RNO−) and a hydroxylamine derivative
(RNHOH) (Veeranagouda et al., 2014). The pyruvate-ferredoxin
oxidoreductase (PFOR) is a key enzyme required for the
reduction and activation of MTZ (PFOR-dependent activation;
Leitsch et al., 2011). The enzyme is metabolically involved in
the pathway of oxidative decarboxylation of pyruvate with the
participation of thiamine followed by the transfer of an acetyl
moiety to coenzyme A, for the synthesis of acetyl-CoA (Kletzin
and Adams, 1996). We have identified three genes encoding
for the subunits alpha (BF9343_4129), beta (BF9343_4130), and
gamma (BF9343_1572) of PFOR, being alpha and beta subunit-
encoding genes assigned to cluster 6 whereas gamma subunit-
encoding gene to cluster 12 (Supplementary Table S3). The fact
of these genes grouped into two clusters could be explained once
the genes encoding for the subunits alpha and beta are belonging
to the same operon, whereas the corresponding gamma subunit-
encoding gene is part of another operon altogether the ORF
BF9343_1571 (Pertea et al., 2009).
The expression of PFOR genes showed enhanced levels
in the subcultures collected after drug exposure (Mtz2 and
Mtz8) and decreased levels in both the starting culture
(wMtz) and after the drug removal (rMtz2 and rMtz8;
Supplementary Table S3; Supplementary Figure S1). Down-
regulation of PFOR genes have already been associated to
metronidazole resistance in both B. fragilis and other bacteria
(Diniz et al., 2004; Leitsch et al., 2011).
Among another enzymatic systems described in anaerobic
microorganisms thought to be involved in metronidazole
activation, the nitroreductases catalyze the reduction of nitro
groups and in the metabolic process oxidize NAPH to NADP+
(nitroreductase-dependent activation; Sisson et al., 2000; Leitsch
et al., 2011). In our experiments, a gene (BF9343_0189) encoding
for an oxygen-insensitive NAD(P)H nitroreductase showed high
expression level in subcultures grown under pressure of SIC of
metronidazole and was related to cluster 10 (Supplementary
Table S3).
Although, the 200 amino acid sequence of BF9343_0189
showed low similarity (BLASTp > 30%) with either NfsB of
Escherichia coli or RdxA of Helicobacter pylori, it contains
a nitroreductase domain (InterPro ID IPR029479, from S4
to K200) and the nitroreductase family signature (Pfam ID
Frontiers in Microbiology | www.frontiersin.org 6 September 2016 | Volume 7 | Article 1465
fmicb-07-01465 September 16, 2016 Time: 10:20 # 7
de Freitas et al. B. fragilis RNA-seq upon Metronidazole Pressure
FIGURE 4 | K-means clustering. Graded response to changes in 48 h of anaerobic subculture of Bacteroides fragilis ATCC43859 revealed by k-means clustering
set to 15.
TABLE 2 | Primer sequences used to validate the gene transcription levels
obtained by RNA-seq approach.
Locus ID Gene/ORF name Sequence primers (5′–3′)
BF9343_0382 gadB F-TGGCAGATTGAGATGCGTCA
R-CAGACCGGTCCATGTAACCC
BF9343_3128 BF9343_3128 F-CTCATCCATCCTGACCGACG
R-GCAGTTCGGAGTTTTGCTGG
BF9343_2131 pyrD2 F-CAGGGTTGGCAGTTTTTCG
R-ACCCGGTACAGACGAGTACA
BF9343_3319 gdhB2 F-TCTCCACGCGGAAAGTCAAA
R-GTCGGTTTCAGGACCGATGT
BF9343_3934 BF9343_3934 F-TGTCACTGAATTGAGGGCGT
R-ACCATCCGAAAGACAGACCG
BF9343_0081 BF9343_0081 F-CACATGTCCATAGCCGTCGT
R-CTGATCGCCCTTCATCCACA
PF00881 from K10 to G178) which highly suggests to be a
putative nitroreductase involved in the reduction of nitrogen-
containing compounds, including those containing the nitro
functional group. This response of high PFOR and nitroreductase
expression levels were expected, since the wild-type B. fragilis
strain used in our experiments is not metronidazole-resistant.
Otherwise, metronidazole reduction inside de B. fragilis cells
should become active.
On the other hand, a metabolic shift away to PFOR-dependent
activation pathways is related to conversion of pyruvate to lactate
via lactate dehydrogenase (LDH). This is another pathway that
avoids the activation of nitroimidazoles by reducing pyruvate
to lactate, instead of its metabolism to acetyl-CoA. Indeed,
it was already observed in B. fragilis high LDH activity
compensating for decreased pyruvate ferredoxin oxidoreductase
activity related to metronidazole resistance (Narikawa et al., 1991;
Diniz et al., 2004). Also, similar mechanism was observed in
H. pylori (Kaihovaara et al., 1994). From our k-means clustering
analysis, we identified in the cluster 13, the ORF BF9343_0467
(Supplementary Table S3) encoding for an enzyme LDH
belonging to L-lactate/malate dehydrogenase family (InterPro
ID IPR001557) that catalyzes the reversible NAD-dependent
interconversion of pyruvate to L-lactate. As demonstrated
in Supplementary Figure S1, the expression intensity of
BF9343_0467 was higher than the expression intensity of other
three genes encoding for the PFOR. Consequently, since this
experiment was carried out at anaerobic condition, we may
suggest that under SIC of metronidazole, B. fragilis (Mtz2 and
Mtz8) are expressing different levels of pyruvate metabolizing
enzymes.
As mentioned above, after metronidazole activation, the
nitro radical-anion intermediate derivatives may become a
reactive cytotoxic species and could be impaired by aminothiol
radical scavengers and radioprotectors, normally present in
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TABLE 3 | Validation of RNA-seq data by qRT-PCR.
Target ID Product description Expression by qRT-PCR,∗ % Expression by RNA-seq,∗ % Response to Mtz exposure
BF9343_0382 Glutamate decarboxylase beta 41.03 81.45 Downregulation
BF9343_3128 RNA polymerase sigma-E
factor
42.34 88.42 Downregulation
BF9343_2131 Dihydroorotate dehydrogenase 39.69 74.94 Downregulation
BF9343_3319 Glutamate dehydrogenase 26.88 86.13 Downregulation
BF9343_3934 Related surface antigen protein 464.12 126.41 Upregulation
BF9343_0081 4-deoxy-L-threo-5-hexosulose-
uronate
ketol-isomerase
201.71 126.18 Upregulation
∗After subtracting the transcript abundances in the wMtz from those determined for the Mtz8, the increased abundance in the treatment with metronidazole was related
to the abundance in the wMtz that was normalized to 100%. Values > 100% means upregulation in Mtz8 and values < 100% means downregulation in Mtz8.
FIGURE 5 | Summarized B. fragilis response to metronidazole after exposure to SIC. The mechanisms thought to be involved as described in this manuscript
were ranging from metronidazole activation (via PFOR and nitroreductase), defense against superoxide ions (via antioxidant stress-related enzymes) or impaired
reduction and activation of metronidazole (via LDH), high expression level of multidrug efflux pumps (TolC, HlyD, HlyB), and DNA repair (RecF, RecN, UvrA). Proteins
names in green denote genes with high expression intensity whereas in red denote genes with low expression intensity under the exposure of metronidazole SIC.
the cell (Edwards, 1980). Regarding this type of protection
against the radical-anion intermediate derivatives, we identified
a few genes with high expression level during metrodidazole
exposure, such as the sodB gene (cluster 8, Supplementary
Table S3) encoding for a superoxide dismutase (SOD), which
is a major enzyme produced by microorganisms to evade the
potentially damaging reactive oxygen species (ROS). SODs are
metalloenzymes that use a redox-active metal to unbalanced
two molecules of superoxide (O2−) to oxygen (O2) and
hydrogen peroxide (H2O2), the latter of which can be removed
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by catalase and peroxidase enzymes (Broxton and Culotta,
2016).
In Gram-negative bacteria, two intracellular cytosolic SODs
(Mn-SodA and Fe-SodB) play important roles in the removal
of intracellular superoxide anion (O2−) (Broxton and Culotta,
2016). Considering the intermediate superoxide anion (RNO2−)
generated after metronidazole intracellular reduction, it has been
reported an increased expression of iron-containing superoxide
dismutase (Fe-SOD, sodB) in Entamoeba histolytica (Wassmann
et al., 1999).
Again, once our experiments were carried out at anaerobic
conditions, a putative functional Fe-SodB would be transferring
the two molecules of superoxide anion (O2−) to hydrogen
peroxide (H2O2). Besides, the gene katA encoding for a
catalase (cluster 15, Supplementary Table S3), as well as
the ORF BF9343_3557 encoding for a putative peroxidase
enzyme (cluster 14, Supplementary Table S3), both showed
high expression level under drug selective pressure (Mtz2
and Mtz8). Same phenomenon was observed considering the
ahpC gene (BF9343_1149 in cluster 2) encoding for another
predicted peroxidase enzyme, in particular a peroxiredoxin
(Supplementary Table S3; Choi et al., 1998). The ahpC encodes
for an AhpC protein that is a potent antioxidant stress-related
enzyme converting hydrogen peroxide (H2O2) to water (H2O).
AphC protein levels have been observed to be increased during
metronidazole exposure in H. pylori (McAtee et al., 2001).
Interesting, the expression level of ahpC is activated by hydrogen
peroxide, which would explain our results (Rocha and Smith,
1999). At that moment, our findings may suggest that under
stress imposed by SIC of metronidazole, one of the B. fragilis
responses may be to destroy superoxide radical anion (RNO2−)
via the Fe-SOD pathway and peroxidase enzymes. Metronidazole
resistance related to oxidative stress has already been reported
for H. pylori. In this situation, the oxidative stress response
is mediated through homeostatic regulator HsrA. SOD showed
an inverse relationship between HsrA levels and SOD activity,
suggesting that HsrA may serve as repressor of sodB, while
activate oxidative defense genes in response to low levels of
drug toxic metabolites, before becoming available to interact with
cellular components (Olekhnovich et al., 2014).
On the other hand, among the bactericidal effects related to
metronidazole, it is the generation of single-stranded (ss) and
double-stranded (ds) DNA breaks (Edwards, 1980; Diniz et al.,
2000; Sisson et al., 2000). Several studies have been performed in
order to analyze the role of DNA repair proteins in the response
to the metronidazole treatment (Casanueva et al., 2008; Steffens
et al., 2010). It was already been shown that B. fragilis strain
overexpressing the RecA protein exhibited increased resistance
to this drug, being the RecA a major DNA repair protein that
performs homologous recombination repair and controls the
SOS response (Steffens et al., 2010).
The double-strand-break repair (DSBR) model begins with
processing of the linear duplex DNA at the double-strand-break
(DSB) to generate the ssDNA, needed for DNA strand invasion
of a dsDNA homolog by RecA protein (Szostak et al., 1983). In
case of RecA protein fails to assemble on the ssDNA produced,
then accessory proteins RecF, RecO, and RecR can assist this
assembly step (Umezu and Kolodner, 1994). From our k-means
clustering analysis, recA gene (BF9343_1121), assigned to cluster
11 (Supplementary Table S3), showed low expression level
during the subculture with SIC of metronidazole, if compared
to the subculture without the drug, and further, showing lowest
expression level after removal of the drug (Supplementary
Figure S2). In this analysis, we have also identified the recF
and recN genes, which were assigned to the clusters 14 and 3,
respectively (Supplementary Table S3). Supplementary Figure
S2 also shows the gene expression profile of recF and recN genes,
which differs between them as well as when compared with the
profile of the recA gene. While the recN gene showed an increased
expression level in the second subculture under metronidazole
exposure (Mtz8) when compared to the subculture without the
drug (wMtz), the recF gene had increased expression at both the
first metronidazole subculture (Mtz2) and then immediately after
drug removal (rMtz2).
Firstly, these results suggest that the RecA protein would
not be completely involved in the DNA repair at SIC of
metronidazole, but in that situation, both RecF and RecN would
be functioning. However, RecF would be initially functional as
long as metronidazole enters the bacterial cell, and until very
shortly after the drug has been removed or degraded.
Regarding the RecN protein function, it has been
demonstrated in Deinococcus radiodurans that it is needed
in the DSBR, stimulating the intermolecular association of linear
duplex DNA (Reyes et al., 2010). Meanwhile, it has been showed
that expression of the RecN protein may vary widely among
bacteria. For example, in E. coli expression of RecN is highly
regulated and it is thought unlikely that has a role in the early
steps of DSB repair (Meddows et al., 2005). Add to that, for
D. radiodurans, it is suggested a housekeeping role for RecN
in genome maintenance, even though it is required for DNA
damage tolerance (Funayama et al., 1999; Kidane et al., 2004;
Tanaka et al., 2004). According to our results we may suggest
that in B. fragilis, the recN gene seems to be required for DNA
damage tolerance after treatment with SIC of metronidazole.
Other proteins involved in DNA damage repair observed in
our experiments were UvrA and UvrB, which belong to the
excision nucleotide repair (NER) pathway (Kuzminov, 1999). In
E. coli it has been shown that NER system is involved in DNA
damage repair associated to metronidazole action (Jackson et al.,
1984). Supplementary Figure S3 shows the expression intensity
of genes uvrA1, uvrA2 and uvrB, which have been associated with
the clusters 11, 12, and 6, respectively (Supplementary Table S3).
It is clearly noticeable that the uvrA2 gene is the only one whose
expression is increased upon drug exposure (Mtz2 and Mtz8).
The comparison between the amino acid sequences of UvrA1
and UvrA2 reveals low identity (BLASTp, 46%), differing in
the functional domain architecture. While UvrA2 contains two
domains ABC transporter-like (IPR003439; Y339 to L575 and
R587 to Q919), UvrA1 carries only one (G608 to R936).
According to their domain architecture, it is accepted that UvrA
consists of two ATP-binding domains separated by a linker
region, and in turn, each of these contain a Walker A motif (A1
and A2), a Walker B motif (B1 and B2), and an ABC-signature
sequence (ABC1 and ABC2) (PDB entry: 2R6F) (Pakotiprapha
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et al., 2008). Then, in view of this UvrA topology, it seems that
the functional copy may be the uvrA2 gene instead of uvrA1, as
it showed to be overexpressed in our experiments. Functionally,
UvrA is the first protein in the NER cascade, initially detecting
distortions in the DNA double helix. The knowledge about the
UvrA molecular function is based on the crystal structure of an
UvrA dimer in complex with damaged DNA, which allows UvrA
to distinguish damaged from non-damaged DNA (Jaciuk et al.,
2012).
Recently, it has been reported that UvrA performs two
different mechanisms in order to detect a potential DNA lesion
within a large extension of non-damage DNA, which are UvrB-
dependent and UvrB-independent (Kad et al., 2010). Namely,
UvrA alone can perform a three-dimensional searching by only
short-term binding events and jumping between different DNA
molecules. Otherwise in the presence of UvrB, UvrA forms an
UvrAB complex applying a one-dimensional search by sliding
along the DNA (Kad et al., 2010). By the results shown here,
possibly UvrA is performing a three-dimensional searching for
detecting a possible DNA damage in an UvrB-independent way
rather than a one-dimensional searching through an UvrAB
complex. The uvrB gene is less expressed than uvrA under
metronidazole pressure and in the first subculture after drug
removal (Supplementary Figure S3).
Different authors have demonstrated in B. fragilis another
gene playing a role in resistance against metronidazole and other
DNA damaging agents, namely reg (BF9343_3162) encoding
for an AraC-family regulatory proteins (Casanueva et al.,
2008). In our experiments, the expression analysis of reg gene
(BF9343_3162 or BF3248, assigned to cluster 2, Supplementary
Table S3) showed a different expression profile compared to rec
or uvr genes displaying increased expression intensity upon drug
exposure, and still after 48 h after drug removal (Supplementary
Figure S3). Also, by our K-means clustering, the reg expression
profile was different from those reported for the homologous
gene (BF638R3281) in B. fragilis 638R, in which it is expressed
constitutively.
Furthermore, previous studies had demonstrated diminished
expression of bacterioferritin-encoding gene (bfr; Diniz et al.,
2004). In H. pylori and E. coli, Bfr or Dps (DNA protection
during starvation protein) is known as a protein involved in
DNA protection during the oxidative stress by sequestering
intracellular Fe2+ and storing it in the form of Fe3+, where
one hydrogen peroxide oxidizes two Fe2+, preventing hydroxyl
radical production by the Fenton reaction (Nair and Finkel,
2004). Although, these bacteria are considered microaerophilic
(H. pylori) or facultative anaerobic (E. coli), we still wanted
to investigate the expression of the bfr or dps homologous
gene in B. fragilis under anaerobic conditions. Therefore, we
also check over the expression level of bacterioferritin like-
encoding genes and verified the ORF BF9343_1253 (cluster
15, Supplementary Table S3), which has homology (BlastP,
similarity > 55% and coverage > 80%) whit H. pylori dps
gene (HP_0243) and showed lower expression intensity during
SIC exposure of metronidazole if comparing to wMtz or rMtz
(Supplementary Table S3). This observation is in agreement with
literature data (Diniz et al., 2004) and may suggest that the DNA
protection during the oxidative stress imposed by metronidazole
pressure should not exclusively depend on bacterioferritin-like
protein.
According to the literature, the efficiency of the metronidazole
action on DNA might depend on the degree of strand breakage
and aminothiol protection efficiency (Edwards, 1980). Hence, our
results may suggest an important role of peroxidases and Fe-SOD
in bacteria protection against nitro radical-anions, rather than
only for DNA repair systems.
In spite of the genes described above, whose expression
patterns showed a high intensity during metronidazole exposure,
suggesting their involvement in resistance, others might also
be involved, such as those encoding for multidrug (MDR)
eﬄux pumps, e.g., BF9343_0579, BF9343_2447, BF9343_2448
and BF9343_2449, and all fell into cluster 14 (Supplementary
Table S3). The BF9343_0579 encodes for a putative AcrB,
which is a member of AcrAB multi-drug eﬄux system that is
believed to protect the bacterium against hydrophobic inhibitors;
BF9343_2447, BF9343_2448, and BF9343_2449 that were more
expressed during metronidazole exposure (Supplementary Table
S3) codify for the three components of a homologous E. coli
α-hemolysin (HlyA) type I secretion system, TolC, HlyD,
and HlyB, respectively (Ma et al., 1993). With regards to
metronidazole, active eﬄux systems had already been associated
to H. pylori resistance, although this is not an anaerobic
bacterium, such as B. fragilis. The eﬄux systems were found to be
expressed in multiple H. pylori isolates in vitro and are related to
outer membrane eﬄux proteins (OEPs: TolC), periplasmic eﬄux
proteins (PEPs: AcrA, EmrA, HlyD), and inner membrane eﬄux
proteins (IEPs: AcrB) (Amsterdam et al., 2005; Liu et al., 2008).
Considering TolC homologous eﬄux pumps (HP0605, HP0971,
HP1327, and HP1489) (Mehrabadi et al., 2011), a high amino
acid sequence similarity was observed between BF9343_2447
and HP1489 (BlastP, similarity 49%, query coverage 83% and
subject coverage 84%), which adds more evidences for the
results observed in this study. Indeed, the protein sequences of
BF9343_2447, 9343_2448 and BF9343_2449 contain TolC family
signature (from L29 to I486), HlyD domain (from A212 to G324)
and ATP-binding cassette transporter signature (from C41 to
A386), respectively.
Interestingly, besides to secrete α-hemolysin (HlyA), this
eﬄux system can also secrete heterologous proteins. Actually,
almost 400 proteins are secreted in vitro by E. coli via the
hemolysin secretion pathway, even though they are entirely
unrelated to HlyA (Gentschev et al., 2002). Particularly, similar
to metronidazole, HlyA is a hydrophilic protein, so in that sense,
we would hypothesize that in B. fragilis the hemolysin secretion
pathway, whose genes are activated in response to metronidazole,
could be mediating the drug eﬄux (Stanley et al., 1998). In
opposition, other genes showed low expression intensity under
SIC of metronidazole. For example, genes encoding for N-acetyl-
beta-hexosaminidase subunits (BF9343_1729 and BF9343_1731),
an oxidoreductase, were grouped into cluster 6 (Supplementary
Table S3).
The N-acetyl-beta-hexosaminidase is related to binding and
deglycosylation of O-glycosylated peptides from mammals and
this function corresponds to a virulence factor, which was
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already been demonstrated in Streptococcus pneumoniae and
B. fragilis (Rao et al., 2006; Cao et al., 2014; Shi et al., 2014).
This unheard result would be considered advantageous from
the clinical viewpoint, since metronidazole would suppress that
virulence gene and thus it would be of interest further in vivo
mutagenesis assays.
Validation of RNA-Seq Data
We chose six direct targets of expressed genes to validate RNA-
seq results by quantitative PCR (qPCR) expression analysis
(Table 2). We used two sampling points, parent wMtz strain, and
after 8 days SIC of metronidazole exposure (Mtz8.1 and Mtz8.2),
with three technical replicates for each sample. The target genes
fell into clusters 3, 6, 10, 11, and 13, respectively (Supplementary
Table S3). Transcript abundance was normalized to that of 16S
rRNA after confirmation that its expression was not significantly
affected under the experimental conditions. Fold-regulation (i.e.,
the ratio of transcript abundance in the sampling point with
metronidazole to that in the sampling point after removal of
metronidazole) showed good agreement between the qRT-PCR
and RNA-seq experiments (Table 3).
CONCLUSION
We have presented here a report providing a whole gene
expression set related to response of B. fragilis ATCC 43859
exposed to SIC of metronidazole. In this approach, we selected
from a wild type B. fragilis ATCC 43859 four derivative strains
subcultured at 48 h intervals in the presence and absence of drug,
under anaerobic conditions.
Overall, according to global gene expression by RNA-seq
analysis, we found that the strains selected after metronidazole
removal were functionally more similar to those selected after
drug exposure, suggesting that even when the growth conditions
are restored to the initial state without the drug, the recovered
strain had drastic changes in their whole gene expression
patterns.
This study addressed a broad range of issues related to
the bacterial response to SIC of metronidazole. As shown in
Figure 5, these mechanisms were ranging from metronidazole
activation inside the cell (via PFOR and nitroreductase), defense
against superoxide ions (via antioxidant stress-related enzymes)
or impaired reduction and activation of metronidazole (via
LDH), high expression level of multidrug eﬄux pumps (TolC,
HlyD, HlyB), to DNA repair (RecF, RecN, UvrA). Mainly, we
highlight that under the pressure of SIC of metronidazole, there
seems to be an increased protection against nitro radical-anions
mediated by peroxidases and Fe-SOD rather than for efficiency of
DNA repair systems.
The results may help to elucidate the global response of
B. fragilis to selective pressure imposed by metronidazole,
especially at SICs, contributing with information about bacterial
survival strategies under stress conditions in their environment.
Despite the methodological limitations and high costs, this
experimental design may be considered an important step,
although a proteomic validation would be of interest, once
some regulatory proteins are post-transcriptional regulated in
prokaryotes, suggesting the need of caution in predicting protein
coding sequences from only RNA-seq data. Further prospective
studies are still needed to better address this issue, especially
considering the genome coverage, and in vivo conditions,
which would reflect an actual infection and antimicrobial
chemotherapy.
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TABLE S1 | Gene Ontology term (GO), biological process, molecular
function or cellular location term of expressed genes identified for wMtz,
Mtz2, Mtz8, rMtz2, rMtz8 strains.
TABLE S2 | Shared core obtained among all tested B. fragilis strains
selected in this study.
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